Antidote Health for the Cure of Cancer Foundation
ActivePhilanthropy & Voluntarism
About Antidote Health for the Cure of Cancer Foundation
The Antidote Health for the Cure of Cancer Foundation concentrates its giving on biomedical cancer research and translational research at major academic medical centers and universities. It makes relatively large, targeted gifts intended to advance cancer cure efforts, supporting both U.S. cancer hospitals and select international research institutions. The foundation appears to prioritize research capacity and discovery over general community services or small operational grants.
Focus Areas
Major academic cancer centers (clinical and translational research)University-based biomedical research programs focused on oncologyInstitutional research capacity and program support for cancer cure initiativesCross-border support for leading cancer research institutions
Who They Fund
people affected by cancer (patients and survivors)oncology researchers and cliniciansresearch institutions and labs
Giving Approach
About Antidote Health for the Cure of Cancer Foundation
Antidote Health for the Cure of Cancer Foundation backs cancer-cure research with relatively large, targeted grants to academic medical centers and universities. In the recent grants list, the largest award was $200,000 to Mount Sinai in New York, followed by $178,089 to Dana Farber Cancer Center in Boston. Those gifts fit a pattern of supporting institutions working on oncology research rather than broader service delivery. The foundation’s stated program areas point to translational and clinical work, including liquid biopsy research for lung cancer detection, drug strategies targeting EGFR, and high-risk cancer research with an initial emphasis on non-small cell lung cancer. Its giving also extends beyond the United States, with grants recorded to UZH Foundation in Zurich and Sustech University in Nan Shan Qu. The foundation appears to favor research capacity, discovery, and direct support for scientific teams pursuing cancer cure initiatives. Its grant profile is compact but specialized, with most awards aimed at institutional research environments where investigators can work on diagnostics, resistance mechanisms, and early-stage therapeutic ideas.
What Antidote Health for the Cure of Cancer Foundation Funds
A core theme is lung cancer research. The foundation has an active program supporting liquid biopsy research to improve detection of lung cancer drivers, including EGFR mutations, and drug resistance mechanisms such as HER2 and MET amplification. Another major line of work focuses on EGFR-targeted therapies. It funds drug discovery research at Dana-Farber Cancer Center, including efforts to overcome osimertinib resistance. The foundation also supports risk-taking cancer research, with an initial priority on non-small cell lung cancer and an emphasis on early-stage, high-risk projects. In a separate line of support, it funded a PPE donation program during COVID-19, including procurement and donation of surgical masks to hospitals and state and local governments. That mix shows a research-centered funder with a limited, specific public-health response role.
How Antidote Health for the Cure of Cancer Foundation Gives
The foundation’s typical grant size is fairly concentrated: the 25th percentile is $99,481, the median is $112,905, and the 75th percentile is $178,089. Recent awards cluster around the same research mission, with repeated support for cancer cure work rather than a broad mix of program types. The structure appears to be a private foundation making institutional grants, and it funds organizations rather than individuals. One of its active programs, Risk-Taking Cancer Research Grants, accepts unsolicited proposals; another research-grants program emphasizes direct engagement with scientists and fewer administrative requirements than traditional funders. The record also shows multi-year support to some recipients, including grants in both 2023 and 2025 to Dana Farber Cancer Center.
Financial Snapshot
Annual Giving
$0
Total Assets
$3.3M
Total Revenue
$98K
Total Expenses
$10K
Typical Grant Size
Most grants fall between $99K and $178K, with a median of $113K.
25th Percentile
$99K
Median
$113K
75th Percentile
$178K
Geographic Reach
Regional2 states funded
About 0% of grants go to recipients in MA.
Funding intensity
LowHigh
Headquarters
Funding intensity
LowHigh
Where Antidote Health for the Cure of Cancer Foundation Funds
Top 3 recipient countries by grant volume for Antidote Health for the Cure of Cancer Foundation.
| Rank | Country | Grants | Total | Share |
|---|---|---|---|---|
| 1 | United StatesDomestic | 3 | $478K | 60.0% |
| 2 |
Unlock Deep Analysis
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeSee Similar Funders
Free Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeExplore related grant guides
Want a Personalized Pitch for Antidote Health for the Cure of Cancer Foundation?
Sign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
Free plan available
No contracts
Cancel anytime